Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children

Clinical trial NCT04987762 · TERMINATED

Trial details

NCT number: NCT04987762
Sponsor: Purdue Pharma LP
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit/Hyperactivity Disorder

Start date: 2021-08-03
Primary completion: 2022-04-27
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.